Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Berdel

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
A phase I/II study of a stepwise dose-escalated regimen of cisplatin, etoposide and ifosfamide plus granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with advanced germ cell tumoursC Bokemeyer, H J Schmoll, A Harstrick, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1991
Cisplatin/etoposide/ifosfamide stepwise dose escalation with concomitant granulocyte/macrophage-colony-stimulating factor for patients with far-advanced testicular carcinomaA Harstrick, H J Schmoll, C Bokemeyer, et al.
Critical Reviews in Oncology/Hematology|October 7, 2005
Towards a pathogenesis-oriented therapy of acute myeloid leukemiaW Hiddemann, K Spiekermann, C Buske, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 8, 2012
Prognostic impact of meningeal dissemination in primary CNS lymphoma (PCNSL): experience from the G-PCNSL-SG1 trialA Korfel, M Weller, P Martus, et al.
Cancer Chemotherapy and Pharmacology|October 6, 2001
Remission induction therapy: the more intensive the better?T Büchner, W Hiddemann, W Berdel, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
A phase I/II study of a stepwise dose-escalated regimen of cisplatin, etoposide and ifosfamide plus granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with advanced germ cell tumoursC Bokemeyer, H J Schmoll, A Harstrick, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1991
Cisplatin/etoposide/ifosfamide stepwise dose escalation with concomitant granulocyte/macrophage-colony-stimulating factor for patients with far-advanced testicular carcinomaA Harstrick, H J Schmoll, C Bokemeyer, et al.
Critical Reviews in Oncology/Hematology|October 7, 2005
Towards a pathogenesis-oriented therapy of acute myeloid leukemiaW Hiddemann, K Spiekermann, C Buske, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 8, 2012
Prognostic impact of meningeal dissemination in primary CNS lymphoma (PCNSL): experience from the G-PCNSL-SG1 trialA Korfel, M Weller, P Martus, et al.
Cancer Chemotherapy and Pharmacology|October 6, 2001
Remission induction therapy: the more intensive the better?T Büchner, W Hiddemann, W Berdel, et al.
Pageof 3